Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05877885

Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
84 (estimated)
Sponsor
AdventHealth · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

The goal of this randomized controlled trial is to evaluate the potential of a customized digital cognitive training intervention to target aspects of brain function in apathy of late-life depression and reduce symptoms of apathy and related cognitive and behavioral deficits. The investigators hypothesize that 4 weeks of a customized digital cognitive training program will lead to changes in brain connectivity, apathy severity, and cognitive control performance.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTargeted Cognitive Training InterventionIn this intervention, participants will complete 25-30 minutes of cognitive training per day, 5 days/week (but up to 7 days/week) for 4 weeks. The training protocol will be delivered via the Posit Science Platform, and includes tasks that emphasize training of sustained attention, salience detection, and dimensions of cognitive control. During the 4 week intervention, participants will have weekly 10-20 minute visits with a Care Manager to provide clinical monitoring of symptoms and structured support to participants.
BEHAVIORALGeneral Cognitive Training InterventionIn this intervention, participants will complete 25-30 minutes of cognitive activities per day, 5 days/week (but up to 7 days/week) for 4 weeks. The training protocol will be delivered via the Posit Science Platform. The intervention protocol will include computerized cognitive activities designed to provide general cognitive stimulation. During the 4 week intervention, participants will have weekly 10-20 minute visits with a Care Manager to provide clinical monitoring of symptoms and structured support to participants.

Timeline

Start date
2025-09-19
Primary completion
2028-11-01
Completion
2028-12-01
First posted
2023-05-26
Last updated
2025-10-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05877885. Inclusion in this directory is not an endorsement.